Miao Z, Shen J, Zhang F Q, Hu K, Hou X R, Lian X, Sun S, Yan J F, Liu Z K
Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1014-1019. doi: 10.3760/cma.j.cn112152-20191031-00705.
To investigate the relationship between human papillomavirus (HPV) integration and prognosis of cervical cancer patients. The data of 82 patients with cervical cancer treated in the Radiotherapy Department of Peking Union Medical College Hospital from October 2004 to June 2012 were retrospectively analyzed.The patients were divided into poor prognosis group (recurrence or metastasis after surgery and adjuvant radiotherapy) and good prognosis group based on a propensity score matching strategy.The HPV integration of the two groups were detected by whole exome sequencing to determine whether the integration sites were located in the common fragile sites (CFSs). HPV integration and integration into CFSs were compared between the two groups. Among the enrolled 82 patients, 37 were divided in poor survival group and 45 in good survival group. A total of 90 integration breakpoints were identified, 30 of them occurred in poor prognosis group and 60 occurred in good prognosis group. In the poor prognosis group, HPV integration occurred in 20 patients, 13 of them were inserted in CFSs of 11 patients, and the numbers in good prognosis group were 26, 17, 11, respectively. There were no significantly statistical differences in the number of HPV integration events (=0.289), HPV integration patients (=0.735), CFSs integration events (=0.427), and CFSs integration patients (=0.591) between the two groups. In poor prognosis group, more CFSs integration events occurred in patients with metastasis than those in patients with only local recurrence (9 vs 2, =0.003). No significant differences are observed in HPV integration and HPV integration into CFSs between cervical cancer patients with different prognoses. HPV integration into CFSs may be associated with distant metastasis.
探讨人乳头瘤病毒(HPV)整合与宫颈癌患者预后的关系。回顾性分析2004年10月至2012年6月在北京协和医院放疗科接受治疗的82例宫颈癌患者的数据。采用倾向评分匹配策略将患者分为预后不良组(手术及辅助放疗后复发或转移)和预后良好组。通过全外显子测序检测两组患者的HPV整合情况,以确定整合位点是否位于常见脆性位点(CFSs)。比较两组之间HPV整合及整合入CFSs的情况。在纳入的82例患者中,37例分为生存不良组,45例分为生存良好组。共鉴定出90个整合断点,其中30个发生在预后不良组,60个发生在预后良好组。在预后不良组中,20例患者发生HPV整合,其中13例插入11例患者的CFSs中,在预后良好组中的相应数字分别为26、17、11。两组之间HPV整合事件数量(=0.289)、HPV整合患者数量(=0.735)、CFSs整合事件数量(=0.427)及CFSs整合患者数量(=0.591)均无显著统计学差异。在预后不良组中,发生转移的患者比仅局部复发的患者发生更多CFSs整合事件(9比2,=0.003)。不同预后的宫颈癌患者在HPV整合及HPV整合入CFSs方面未观察到显著差异。HPV整合入CFSs可能与远处转移有关。